基于生理学的药物动力学建模用于儿科患者的药物剂量:临床护理实用方法教程
Joyce E M van der Heijden1, Jolien J M Freriksen1, Marika A de Hoop-Sommen1
1Division of Pharmacology and Toxicology, Department of Pharmacy, Radboud University Medical Center, Nijmegen, The Netherlands.
Clinical pharmacology and therapeutics
|August 9, 2023
概括
基于生理学的药理动力学 (PBPK) 建模为儿科药物剂量的证据差距提供了解决方案. 本教程介绍了PBPK工作流程,以支持儿童的模型知情剂量 (MID).
科学领域:
- 药理动力学和药物开发
- 儿科药理学 儿科药理学
- 计算生物学 计算生物学
背景情况:
- 标签外的儿科药物剂量往往缺乏强有力的证据.
- 对于儿科剂量的传统证据来源往往是不够的.
- 基于生理学的药理动力学 (PBPK) 建模提供了一个科学合理的方法来解决这些证据缺口.
研究的目的:
- 为基于PBPK的儿科建模提供一个实用的工作流程.
- 在儿科临床实践中指导实施基于模型的剂量 (MID).
- 支持建模人员,研究人员和临床医生利用PBPK模拟用于儿科药物剂量.
主要方法:
- 为儿科应用量身定制的实用PBPK建模工作流程的开发.
- 强调理解模型假设和成功实施的限制.
- 将PBPK模拟集成到一个全面的基于模型的剂量策略中.
主要成果:
- 为儿科药物剂量提供了一个结构化的PBPK工作流.
- 强调了评估MID方法的好处和风险的重要性.
- 该教程旨在提高PBPK模拟在儿科的有效使用.
结论:
- PBPK建模是产生基于证据的儿科剂量建议的宝贵工具.
- 成功实施MID需要对PBPK模型有深入的了解,并仔细评估风险和收益.
- 这种工作流便于应用PBPK模拟来改善儿科药物治疗.
相关概念视频
Pharmacokinetic Models: Comparison and Selection Criterion
104
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
104
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
96
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
96
Pharmacokinetic Models: Overview
786
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
786
Model Approaches for Pharmacokinetic Data: Physiological Models
75
Physiological models in pharmacokinetics are instrumental in understanding the distribution and elimination of drugs within the body. These models describe the drug concentration within target organs, influenced by factors such as drug uptake, tissue volume, and blood flow. Drug uptake is governed by the partition coefficient, which signifies the drug concentration ratio in tissue to that in the blood. The blood flow rate to a specific tissue is expressed as Qt, and the rate of change in tissue...
75
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
61
Drug transporters are critical in drug absorption, distribution, and excretion processes. They should be included in physiological-based pharmacokinetic (PBPK) models, which help predict human drug disposition. However, predicting this is challenging during drug development, especially when liver transport is involved. However, with a realistic representation of body transport processes, an accurate model may be possible.
A recent model describes pravastatin's hepatobiliary excretion,...
A recent model describes pravastatin's hepatobiliary excretion,...
61
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches
181
Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
181


